Whether restoring youthful GHK-Cu levels would have clinically meaningful effects on aging is speculative
Subcutaneous dosing in research protocols is typically in the 1-2 mg range, though specific doses depend entirely on the study design and model
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
Although high doses of B12 are generally considered safe due to its water-soluble nature, most individuals can obtain sufficient B12 through a balanced diet that includes foods like meat, eggs, and fortified cereals
This simplifies cell culture applications and eliminates solvent-related confounding factors
The real mechanism (lowering the stress hormone cortisol that impairs the prefrontal cortex and hippocampus, plus a GABA-mimetic and mild acetylcholinesterase action)